NOVN.SW vs. BN

Last updated Jun 5, 2026

NOVN.SW (Novartis AG) and BN (Brookfield Corporation) are both stocks. NOVN.SW operates in Drug Manufacturers - General (Healthcare), while BN operates in Asset Management (Financial Services). Over the past 10 years, NOVN.SW returned 9.98%/yr vs 12.46%/yr for BN. At a 0.27 correlation, their price movements are largely independent.

Performance

NOVN.SW vs. BN - Performance Comparison

The chart below illustrates the hypothetical performance of a CHF 10,000 investment in Novartis AG (NOVN.SW) and Brookfield Corporation (BN). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NOVN.SW is traded in CHF, while BN is traded in USD. To make them comparable, the BN values have been converted to CHF using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVN.SW achieves a 8.91% return, which is significantly higher than BN's -2.36% return. Over the past 10 years, NOVN.SW has underperformed BN with an annualized return of 9.98%, while BN has yielded a comparatively higher 12.46% annualized return.

NOVN.SW

• 1D: 2.04%
• 1M: 2.19%
• YTD: 8.91%
• 6M: 11.93%
• 1Y: 22.96%
• 3Y*: 14.41%
• 5Y*: 12.76%
• 10Y*: 9.98%

BN

• 1D: 0.00%
• 1M: -2.85%
• YTD: -2.36%
• 6M: -5.01%
• 1Y: 10.61%
• 3Y*: 23.83%
• 5Y*: 9.21%
• 10Y*: 12.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVN.SW vs. BN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NOVN.SW Novartis AG	8.91%	27.98%	8.44%	11.93%	8.75%	-0.11%	-5.39%	28.50%	6.51%	16.04%
BN Brookfield Corporation	-2.87%	5.32%	55.54%	17.09%	-33.91%	53.70%	-0.20%	50.08%	-9.79%	28.14%

Correlation

The correlation between NOVN.SW and BN is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (10Y) Calculated over the trailing 10-year period	0.21
Correlation (All Time) Calculated using the full available price history since Sep 3, 2007	0.27

Over the past year, the correlation between NOVN.SW and BN has dropped to 0.06 - well below their long-term average of 0.27, suggesting their price drivers have been diverging.

Return for Risk

NOVN.SW vs. BN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVN.SW

NOVN.SW Risk / Return Rank: 75
NOVN.SW Sharpe Ratio Rank: 79
NOVN.SW Sortino Ratio Rank: 72
NOVN.SW Omega Ratio Rank: 72
NOVN.SW Calmar Ratio Rank: 77
NOVN.SW Martin Ratio Rank: 77

BN

BN Risk / Return Rank: 55
BN Sharpe Ratio Rank: 59
BN Sortino Ratio Rank: 51
BN Omega Ratio Rank: 50
BN Calmar Ratio Rank: 57
BN Martin Ratio Rank: 60

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVN.SW vs. BN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and Brookfield Corporation (BN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NOVN.SW	BN	Difference
Sharpe ratio: Return per unit of total volatility	1.34	0.37	+0.96
Sortino ratio: Return per unit of downside risk	1.80	0.69	+1.11
Omega ratio: Gain probability vs. loss probability	1.24	1.09	+0.15
Calmar ratio: Return relative to maximum drawdown	2.29	0.47	+1.83
Martin ratio: Return relative to average drawdown	5.53	1.26	+4.27
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NOVN.SW vs. BN - Sharpe Ratio Comparison

The current NOVN.SW Sharpe Ratio is 1.34, which is higher than the BN Sharpe Ratio of 0.37. The chart below compares the historical Sharpe Ratios of NOVN.SW and BN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NOVN.SW	BN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.34	0.37	+0.96
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	0.30	+0.42
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.55	0.41	+0.14
Sharpe Ratio (All Time) Calculated using the full available price history	0.48	0.28	+0.20

Drawdowns

NOVN.SW vs. BN - Drawdown Comparison

The maximum NOVN.SW drawdown since its inception was -42.25%, smaller than the maximum BN drawdown of -70.70%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and BN.

Drawdown Indicators

	NOVN.SW	BN	Difference
Max Drawdown Largest peak-to-trough decline	-42.25%	-70.70%	+28.45%
Max Drawdown (1Y) Largest decline over 1 year	-10.78%	-22.86%	+12.08%
Max Drawdown (3Y) Largest decline over 3 years	-16.86%	-32.82%	+15.96%
Max Drawdown (5Y) Largest decline over 5 years	-16.86%	-41.36%	+24.50%
Max Drawdown (10Y) Largest decline over 10 years	-24.11%	-51.41%	+27.30%
Current Drawdown Current decline from peak	-8.53%	-9.15%	+0.62%
Average Drawdown Average peak-to-trough decline	-11.40%	-19.17%	+7.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.43%	8.44%	-4.01%

Volatility

NOVN.SW vs. BN - Volatility Comparison

The current volatility for Novartis AG (NOVN.SW) is 6.01%, while Brookfield Corporation (BN) has a volatility of 9.16%. This indicates that NOVN.SW experiences smaller price fluctuations and is considered to be less risky than BN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOVN.SW	BN	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.01%	9.16%	-3.15%
Volatility (6M) Calculated over the trailing 6-month period	13.12%	21.79%	-8.67%
Volatility (1Y) Calculated over the trailing 1-year period	18.53%	28.68%	-10.15%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.81%	31.12%	-13.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.23%	30.56%	-12.33%

Dividends

NOVN.SW vs. BN - Dividend Comparison

NOVN.SW's dividend yield for the trailing twelve months is around 3.19%, more than BN's 0.57% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BN Brookfield Corporation	0.57%	0.52%	0.56%	0.70%	1.44%	1.12%	1.55%	1.11%	1.56%	1.29%	1.58%	1.50%
NOVN.SW Novartis AG	3.19%	3.19%	3.72%	3.77%	3.91%	3.94%	3.72%	3.27%	3.98%	3.98%	4.35%	3.58%

Financials

Frequently Asked Questions

Can I hold both NOVN.SW and BN in my portfolio?

NOVN.SW and BN have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.